Youlan L Gu

Summary

Affiliation: University Medical Center Groningen
Country: The Netherlands

Publications

  1. ncbi Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration
    Youlan L Gu
    Department of Cardiology, Thorax Center, University Medical Center Groningen, University of Groningen, Hanzeplein 1 PO Box 30001, 9700 RB Groningen, The Netherlands
    Trials 10:90. 2009
  2. ncbi Computer-assisted quantification of myocardial reperfusion after primary percutaneous coronary intervention predicts functional and contrast-enhanced cardiovascular magnetic resonance outcomes in patients with ST-segment elevation myocardial infarction
    Youlan L Gu
    Department of Cardiology, University Medical Center Groningen, University of Groningen, The Netherlands
    Catheter Cardiovasc Interv 77:174-81. 2011
  3. ncbi Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abc
    Youlan L Gu
    Department of Cardiology, Thorax Center, University Medical Center Groningen, University of Groningen, Hanzeplein 1, PO Box 30001 9700 RB Groningen, Netherlands
    Circulation 122:2709-17. 2010
  4. ncbi Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarct
    Peter Damman
    Department of Cardiology, Academic Medical Center University of Amsterdam, Academic Medical Center Meibergdreef 9, Amsterdam, The Netherlands
    Am Heart J 163:783-9. 2012
  5. ncbi Feasibility and applicability of computer-assisted myocardial blush quantification after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
    Joost D E Haeck
    Department of Cardiology, Academic Medical Center, University of Amsterdam, The Netherlands
    Catheter Cardiovasc Interv 75:701-6. 2010
  6. ncbi Impact of chronic total occlusions on markers of reperfusion, infarct size, and long-term mortality: a substudy from the TAPAS-trial
    Chris P H Lexis
    Department of Cardiology, Thorax Center, University Medical Center Groningen, Groningen, The Netherlands
    Catheter Cardiovasc Interv 77:484-91. 2011
  7. ncbi Is the myocardial blush grade scored by the operator during primary percutaneous coronary intervention of prognostic value in patients with ST-elevation myocardial infarction in routine clinical practice?
    Marthe A Kampinga
    Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Circ Cardiovasc Interv 3:216-23. 2010
  8. ncbi Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction
    Youlan L Gu
    Department of Cardiology, Thorax Center, University Medical Center Groningen, University of Groningen, Hanzeplein 1, PO Box 30001, 9700 RB, Groningen, The Netherlands
    Clin Res Cardiol 100:1069-76. 2011
  9. ncbi Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial
    Marieke L Fokkema
    Thoraxcenter, Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Circ Cardiovasc Interv 2:323-9. 2009

Collaborators

Detail Information

Publications9

  1. ncbi Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration
    Youlan L Gu
    Department of Cardiology, Thorax Center, University Medical Center Groningen, University of Groningen, Hanzeplein 1 PO Box 30001, 9700 RB Groningen, The Netherlands
    Trials 10:90. 2009
    ....
  2. ncbi Computer-assisted quantification of myocardial reperfusion after primary percutaneous coronary intervention predicts functional and contrast-enhanced cardiovascular magnetic resonance outcomes in patients with ST-segment elevation myocardial infarction
    Youlan L Gu
    Department of Cardiology, University Medical Center Groningen, University of Groningen, The Netherlands
    Catheter Cardiovasc Interv 77:174-81. 2011
    ....
  3. ncbi Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abc
    Youlan L Gu
    Department of Cardiology, Thorax Center, University Medical Center Groningen, University of Groningen, Hanzeplein 1, PO Box 30001 9700 RB Groningen, Netherlands
    Circulation 122:2709-17. 2010
    ..Although small-scale studies have suggested beneficial effects of intracoronary over intravenous administration of abciximab, this has not been investigated in a medium-scale randomized clinical trial...
  4. ncbi Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarct
    Peter Damman
    Department of Cardiology, Academic Medical Center University of Amsterdam, Academic Medical Center Meibergdreef 9, Amsterdam, The Netherlands
    Am Heart J 163:783-9. 2012
    ..In this study, we investigated the relation between the multimarker risk score and cardiovascular mechanistic markers of outcomes in STEMI patients undergoing PPCI...
  5. ncbi Feasibility and applicability of computer-assisted myocardial blush quantification after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
    Joost D E Haeck
    Department of Cardiology, Academic Medical Center, University of Amsterdam, The Netherlands
    Catheter Cardiovasc Interv 75:701-6. 2010
    ....
  6. ncbi Impact of chronic total occlusions on markers of reperfusion, infarct size, and long-term mortality: a substudy from the TAPAS-trial
    Chris P H Lexis
    Department of Cardiology, Thorax Center, University Medical Center Groningen, Groningen, The Netherlands
    Catheter Cardiovasc Interv 77:484-91. 2011
    ....
  7. ncbi Is the myocardial blush grade scored by the operator during primary percutaneous coronary intervention of prognostic value in patients with ST-elevation myocardial infarction in routine clinical practice?
    Marthe A Kampinga
    Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Circ Cardiovasc Interv 3:216-23. 2010
    ..However, to the best of our knowledge, no study has determined the clinical use of MBG in routine clinical practice. We determined the prognostic value of MBG scored by the operator during primary PCI in consecutive patients with STEMI...
  8. ncbi Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction
    Youlan L Gu
    Department of Cardiology, Thorax Center, University Medical Center Groningen, University of Groningen, Hanzeplein 1, PO Box 30001, 9700 RB, Groningen, The Netherlands
    Clin Res Cardiol 100:1069-76. 2011
    ....
  9. ncbi Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial
    Marieke L Fokkema
    Thoraxcenter, Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Circ Cardiovasc Interv 2:323-9. 2009
    ..The effect of intracoronary adenosine during primary percutaneous coronary intervention has not been investigated in a large randomized trial...